SMTL ID : 7n0a.1

Structure of Human Leukaemia Inhibitory Factor with Fab MSC1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 5 residues within 4Å: Chain A: T.92, G.95, N.96, Y.146, G.147 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Y.146

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain A: N.116, R.123 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.116, A:R.123, A:R.123 Water bridges: A:N.116 NAG.3: 4 residues within 4Å: Chain A: N.34, A.174, A.177, Q.178 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:A.177 Hydrogen bonds: A:N.34 NAG.4: 1 residues within 4Å: Chain A: N.63 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.63

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.5: 1 residues within 4Å: Chain B: S.81 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hallett, R.M. et al., Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment. Clin.Cancer Res. (2023)

Release Date

2022-06-15

Peptides

Leukemia inhibitory factor: A
MSC-1 Fab Light chain: B
MSC-1 Fab Heavy chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
A

C
B

Leukemia inhibitory factor

MSC-1 Fab Light chain

MSC-1 Fab Heavy chain